genomics

My newest investment: Genalyte — Augmenting Claremont Creek Ventures’ Digital Healthcare Tools Portfolio

By Brad Webb / April 2, 2012 / 0 Comments

I’m excited that we have recently added a new portfolio company Genalyte to the Claremont Creek digital healthcare family. I’ll be joining the Board, and I am looking forward to working with founder and CEO Cary Gunn and the Genalyte team. Genalyte is a developer and manufacturer of advanced biomarker detection technology strategically located right […]

Read More

Meet our team

Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.

Nat_Boldhaber7718 -1200px

NAT GOLDHABER

Nat Goldhaber is a co-founder of Claremont Creek Ventures. 

READ MORE
Brad_Webb8124 1200px crop

BRAD WEBB

Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.

READ MORE
Randy_Hawks7690 -1200px

RANDY HAWKS

Randy Hawks is a co-founder of Claremont Creek Ventures.

READ MORE

Post Categories

Keywords

bionics corporate venture funding targeted customer segments mentoring carried interest DOOH stem cell thermoelectric solar private equity swtching costs video energy conservation angel investor chromosone screening Series B SVASE gene disorder testing funding M&A innovation exit energy storage Digital Healthcare government programs awards IPO startups Personalized Pharmacology market uncertainty government policies government funding renewable energy bioinformatics power generation energy tech healthcare cleantech smartgrid greentech words-of-wisdom cloud computing market conditions early-stage genetic screening

Archives